Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01639495 · ClinicalTrials.gov registry record · Phase 3
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS
A Phase 3 study, sponsored by Biosense Webster.
- Completed
- Registry status
- Phase 3
- Development phase
- 148
- Enrollment target
NCT01639495 is a Phase 3 study that has completed, run by Biosense Webster. The registered enrollment target is 148 participants.
The verdict
NCT01639495, a Phase 3 study, has completed, sponsored by Biosense Webster.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 148 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, non-randomized continued access clinical evaluation utilizing the THERMOCOOL® SMARTTOUCH™ catheter.
Interventions
- DEVICE THERMOCOOL® SMARTTOUCH™ Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2012-07-01 |
| Est. Completion | 2014-10-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01639495
The ClinicalTrials.gov registry entry for NCT01639495 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biosense Webster, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which THERMOCOOL® SMARTTOUCH™ Catheter is the first listed.
NCT01639495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01639495 about?
NCT01639495 is a clinical study titled "THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS". This is a prospective, multicenter, non-randomized continued access clinical evaluation utilizing the THERMOCOOL® SMARTTOUCH™ catheter.
What is the current status of trial NCT01639495?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 148 participants. The study started on 2012-07-01. Estimated completion is 2014-10-01.
What interventions are being tested in trial NCT01639495?
The interventions under investigation include: THERMOCOOL® SMARTTOUCH™ Catheter (DEVICE).
Who is sponsoring clinical trial NCT01639495?
This trial is sponsored by Biosense Webster, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.